Evaluating the Effect of Body Mass Index on Procalcitonin Level in Patients with Pneumonia: A Retrospective Cross-Sectional Study
Procalcitonin (PCT) is commonly used to evaluate the etiology and severity of pneumonia. PCT has been shown to be elevated at baseline in patients with obesity. The aim of this study is to determine if body mass index (BMI) has an influence on admission PCT level in patients admitted to the hospital...
Saved in:
| Main Authors: | Mohammad Z. Khrais, J. Curran Henson, Jake Smith, Nikhil Meena |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Advances in Respiratory Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2543-6031/93/1/1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategy for Procalcitonin-Controlled Antimicrobial Therapy in the COVID-19 Pandemic
by: A. A. Zaytsev, et al.
Published: (2022-11-01) -
Evaluation of Serum Levels of Procalcitonin and C-Reactive Protein as Prognostic Indicators in Burns
by: Aparna Sinha, et al.
Published: (2021-09-01) -
Predictive value of serum procalcitonin level for the diagnosis of bloodstream infections in hematological patients
by: Qi Sun, et al.
Published: (2025-02-01) -
Is serum procalcitonin level a reliable indicator in early diagnosis of congenital pneumonia?
by: Davut Bozkaya, et al.
Published: (2019-02-01) -
Serum ferritin-procalcitonin ratio as a predictor of outcomes in hospitalized patients with COVID-19 pneumonia
by: Soliman Belal Soliman, et al.
Published: (2025-05-01)